Skip to content

Marfan Syndrome and Quality of Life of Pediatric Patients

Marfan Syndrome: the Impact on the Quality of Life, Phenotypic Manifestations on Self-image and Self-management Skills, as an Index of Adaptation to the Disease in Pediatric Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05748314
Acronym
MarfanPed
Enrollment
80
Registered
2023-02-28
Start date
2023-01-09
Completion date
2027-05-01
Last updated
2026-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Disorder, Rare Diseases

Keywords

Quality of Life, Self-identification, Self-care

Brief summary

The goal of this observational study is to learn about the impact of Marfan syndrome (MFS) in paediatric affected subjects. the main questions it aims to answer are: * The assessment of quality of life in MFS Italian patients; * The impact of phenotypic manifestations on self-image and self-management skills; * Stratify patients according to the need of psychological support. Participants will take part in the study by completing four self-report questionnaires.

Detailed description

In literature, adolescents with MFS experience difficulty in connecting with peers, and are convinced that they would have been more physically attractive without the disease. Additionally, due to physical activity restrictions and orthopedic limitations, these patients reported having difficulty adjusting and participating in educational events. Data from present study will be able to support clinicians in identifying patients who need psychological support (through parental counseling interviews) aimed at increasing compliance with treatments and adaptation to the disease.

Interventions

OTHERQuestionnaire

KINDL-R; Morisky Medication Adherence Scale;

Sponsors

IRCCS Policlinico S. Donato
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Signed informed consent; * MFS diagnosis according to Revised Ghent criteria (2010);

Exclusion criteria

* Known cognitive deficits

Design outcomes

Primary

MeasureTime frameDescription
Psychological counseling12 monthsQuestionnaire to assess psychological support is KINDL-R (Quality of life);

Countries

Italy

Contacts

PRINCIPAL_INVESTIGATORAlessandro Pini, MD

Cardiovascular-Gentic Centre, IRCCS Policlinico San Donato

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026